Related Experiment Video
Updated: Aug 7, 2026

Strategies for Assessing Autistic-Like Behaviors in Mice
Published on: September 20, 2024
[Autistic disorder: current psychopharmacological treatments and areas of interest for future developments]
Roumen Nikolov1, Jacob Jonker, Lawrence Scahill
1Child Study Center, Yale University School of Medicine, New Haven, CT 06520, USA.
Insights
Current autism treatments offer limited benefits for core symptoms and can have significant side effects. This review explores existing and emerging pharmacotherapies to improve treatment options for pervasive developmental disorders.
Area of Science:
- Neurodevelopmental disorders
- Autism Spectrum Disorder (ASD) research
- Childhood neurodevelopmental conditions
Context:
- Autism and related pervasive developmental disorders (PDDs) are chronic neurodevelopmental conditions impacting children and families.
- Current understanding of autism's causes and pathophysiology remains incomplete.
- Existing pharmacotherapies offer partial relief for maladaptive behaviors but do not address core symptoms and may have significant side effects.
Purpose:
- To review current pharmacotherapies for autism and related PDDs.
- To highlight emerging treatments with potential to improve patient outcomes.
- To address the need for safer and more effective autism medications.
Summary:
- Pharmacological interventions for autism and PDDs primarily target associated behavioral symptoms.
- Current medications often present side effects that can outweigh their therapeutic benefits.
- There is a critical need for novel medications that are both safer and more effective for core autism symptoms.
Impact:
- Enhancing treatment strategies for individuals with autism and PDDs.
- Guiding future research and development of novel autism pharmacotherapies.
- Improving the quality of life for children and families affected by autism spectrum disorder.
Abstract:
Autistic disorder and the group of related conditions defined as pervasive developmental disorders are chronic neurodevelopmental disorders starting in early childhood and affecting a significant number of children and families. Although the causes and much of the pathophysiology of the disorder remain unknown, in recent years a number of available medication treatments have been identified as holding promise in alleviating some of the most disabling maladaptive behaviors, associated with pervasive developmental disorders. However these treatments do not address the core symptoms of the disease and oftentimes their side effects outweigh their benefits. Therefore there is substantial need for new medications that are safer and more effective in addressing the behavior symptoms of autism. The aim of this review is to highlight the available current pharmacotherapies and those emerging treatments with potential to enhance the treatment options of patients with pervasive developmental disorders.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Psychosis: Goals of Pharmacotherapy
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Theoretical Approaches to Psychological Disorder
Biological approach
The biological approach posits that internal, organic factors are the primary causes of such disorders. This perspective emphasizes brain structure and function, genetic predispositions, and neurotransmitter imbalances. For example, schizophrenia has been associated with both genetic...
Psychosis and Antipsychotic Drugs: Overview
Drug Therapy
Antianxiety Medications